title: Carcinoma of unknown primary site--a complete and sustained response with interleukin-2, alpha interferon and 5-fluorouracil/leucovorin.
authors.affiliation: Mount Vernon Cancer Institute, Alexandria, VA 22306.
authors.forename: H P
authors.initials: HP
authors.lastname: Dave
authors.forename: C L
authors.initials: CL
authors.lastname: White
authors.forename: R
authors.initials: R
authors.lastname: Schulof
authors.forename: F P
authors.initials: FP
authors.lastname: Avis
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D007375:Interleukin-1 / Q000008:administration & dosage; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000188:drug therapy*
chemical_list: D016898:Interferon-alpha; D007375:Interleukin-1; D002955:Leucovorin; D005472:Fluorouracil